Transforming data into cures

Data science and artificial intelligence (AI) are driving some of the most promising advances in cancer research and treatment. Your support is helping MSK scientists harness the power of these tools to unlock new insights and change the future of cancer care.

Dr. Sohrab Shah, Chief of Computational Oncology in the Department of Epidemiology and Biostatistics, speaks to an MSK staff member who is sitting in front of a computer monitor displaying an image of cells.

Expanding our understanding of troves of cancer data today

Across MSK, scientists and doctors are generating and studying vast amounts of information, including genomic data, diagnostic images, treatment histories, and clinical outcomes. With AI and other advanced computational tools, they can connect the data in new ways, uncover patterns that might otherwise remain hidden, and accelerate progress for people with cancer.

So more people with cancer can live longer lives tomorrow

Technology and data alone cannot transform cancer care. At MSK, progress is driven by experts who understand both the complexity of cancer and the possibilities of data science, and who know which questions to ask. Your support provides these experts with the resources they need to keep asking the right questions and pursue bold projects that change lives.

MSK innovations save lives

MSK’s Dr. Veronica Rotemberg and Dr. Alina Markova in clinic with a patient.
MSK dermatologists Veronica Rotemberg, MD, PhD, (left) and Alina Markova, MD, are using artificial intelligence and other leading-edge technologies to transform skin cancer detection and treatment.
Watch the video to learn more
MSK's Dr. Luc Morris.
Surgeon-scientist Luc Morris, MD, MSc, is leading research at MSK that is testing whether an artificial intelligence-based model called SCORPIO can better predict how people will respond to certain immunotherapy drugs.
Read more
Dr. Sohrab Shah, standing in front of a white board with graphs on it and smiling.
Sohrab Shah, PhD, Nicholls-Biondi Chair and MSK’s first Chief of Computational Oncology, leads our work dedicated to harnessing MSK’s numerous big data resources and translating biologic knowledge into better patient care. 
Read more
Computational biologist Dr. Dana Pe’er.
Dana Pe’er, PhD, Alan and Sandra Gerry Endowed Chair and Chair of the Computational and Systems Biology Program, says, “What sets MSK apart is the ability for computational and cancer experts to work together as partners.”
Learn more about her work
Dr. Quaid Morris.
Quaid Morris, PhD, a Member of the Computational and Systems Biology Program at SKI, published his first paper on AI more than 30 years ago. He foresees a future in which the technology augments the work of physicians and scientists.
Learn about Dr. Quaid’s lab

MSK donors are advancing progress

Unlocking new insights
Unlocking new insights

A generous gift from the Andrew Sabin Family Foundation will support MSK researchers using artificial intelligence, genomics, and data science to better understand cancer risk and advance prevention strategies.

Read the story
Transforming cancer care
Transforming cancer care

Computational biology and artificial intelligence are playing increasingly important roles in cancer research and care. Generous support from across the MSK Giving community is driving new breakthroughs and discoveries in these fields.

Read more
Bolstering services and careers
Bolstering services and careers

A gift from the Halvorsen Family Foundation is strengthening MSK’s computational oncology initiatives through the Diane and Andreas Halvorsen Center for Computational Oncology Research and two Halvorsen Fellowships.

Learn how donors help
Propelling pathology
Propelling pathology

AI helps doctors interpret digital images and slides to diagnose cancer and track its progression. A gift from the Warren Alpert Foundation positioned MSK as a major hub for digital imaging and computational pathology. 

Learn about computational pathology
Building new tools
Building new tools

A team of MSK researchers developed a new open-source computational method called Spectra to more effectively analyze data at the single-cell level.

Learn about the technology
Unlocking new insights
Transforming cancer care
Bolstering services and careers
Propelling pathology
Building new tools

Help us decipher clues in vast volumes of cancer data

Make a gift
Donate to MSK to fund life-changing research and care.
Donate now
Start a fundraiser
Invite your friends and family to join you in your mission.
Get started
Attend an event
Come to a fundraising event to show your support.
Browse events
To discover more ways to partner in our work, email us.
Contact us
An MSK clinician smiles as she holds a stethoscope to a patient’s chest.

The MSK Campaign: Leading Science. Changing Lives.

The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.

Learn more about The MSK Campaign
An MSK clinician smiles as she holds a stethoscope to a patient’s chest.
Innovating in care delivery Pioneering discovery science Harnessing the immune system Expanding precision oncology Developing the new generation of leaders